Ohr Pharmaceutical Announces Initiation of Investigator Sponsored Trial of Squalamine Eye Drops in Diabetic Macular Edema

[GlobeNewswire] – NEW YORK — Ohr Pharmaceutical, Inc. , a research and development company with a primary focus in ophthalmology, today announced the initiation of a Phase II investigator sponsored clinical trial, OHR-005, … more

View todays social media effects on OHRP

View the latest stocks trending across Twitter. Click to view dashboard

See who Ohr is hiring next, click here to view